Eli Lilly and Company

CDI Pharmacien Industriel 5X8 - F/H

Fegersheim, Grand Est, France

Not SpecifiedCompensation
Mid-level (3 to 4 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical ManufacturingIndustries

Requirements

The ideal candidate is a licensed Industrial Pharmacist (or currently in the process of validation), possessing a Master's degree in Quality Assurance and/or Pharmaceutical Production and/or Pharmaceutical Engineering. They should have a minimum of a Bachelor's degree in a related field and ideally possess a B2 level of English proficiency.

Responsibilities

The CDI Pharmacien Industriel will evaluate the quality of batch assembly and/or finished product dossiers and make decisions regarding the continuation or stoppage of production and/or shipment of finished products based on quality issues. They will manage quality deviations, assess their criticality and impact on products, implement corrective action plans to prevent recurrence, evaluate the quality impact of equipment/process/process modifications, review and approve quality and technical documents and procedures, apply and enforce Good Manufacturing Practices (GMPs), provide quality support to production teams, assist with quality assessment and operator training, support clients internally, lead improvement projects, present QA topics during audits or regulatory inspections, and ensure pharmaceutical coverage for the site.

Skills

GMP
Quality Assurance
Batch Assembly
Finished Product Dossiers
Deviation Management
Corrective Action Plans
Equipment Validation
Process Validation
Quality Documents
Regulatory Inspections
Pharmaceutical Production
Operator Training
Quality Support
Audits
Improvement Projects

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI